BEVERLY, Mass., May 7, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The 53rd Annual J.P. Morgan Global Technology, Media and Communications Conference on May 14th at the Westin Boston Seaport District.The 25th Annual B. Riley Investor Conference on Wednesday, May 21st at the Ritz-Carlton, Marina del Rey, CA.  The 53rd Annual TD Cowen Technology, Media & Telecom Conference on Wedn

Q1 Highlights: Revenue of $192.6 millionGAAP Gross Margin of 46.1%, and Non-GAAP Gross Margin of 46.4%GAAP Operating Margin of 15.1% and Non-GAAP Operating Margin of 18.3%GAAP Diluted earnings per share of $0.88, and Non-GAAP Diluted earnings per share of $1.04BEVERLY, Mass., May 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2025. President and CEO Russell Low commented, "We executed well in the first quarter, delivering strong profitability despite a moderation in customer investments a

BEVERLY, Mass., April 24, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be a sponsor for the Advanced Semiconductor Manufacturing Conference (ASMC) on May 5-8, 2025, at the Hilton Albany, in Albany, New York. This event brings together manufacturers, equipment and materials suppliers, and academia to solve manufacturing challenges with innovative strategies and methodologies. Axcelis will present in Session 5: Contamination Free Manufacturing:

BEVERLY, Mass., April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/

President and CEO Russell Low will Present Keynote Speech at CS Asia BEVERLY, Mass., March 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2025. The event is being held in conjunction with SEMICON China 2025 on March 25-27, 2025, at the Kerry Hotel in Pudong, Shanghai. Axcelis' President and CEO, Russell Low, will present an opening Keynote Speech at the event. I

BEVERLY, Mass., March 12, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that its Board of Directors has approved an additional $100 million in share repurchase authorization. This approval brings the current outstanding repurchase authorization to $215 million. "Axcelis has maintained a strong cash position supported by solid execution over the past several years. This increased share repurchase authorization reflects our confidence in the attractive long-t

BEVERLY, Mass., Feb. 18, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fourteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 27 and 28, 2025. Axcelis management will host one-on-one and small group meetings on Thursday, February 27th with interested investors. For more information on the conferenc

Q4 Highlights: Revenue of $252.4 millionOperating Margin of 21.6%Diluted earnings per share of $1.54BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024. For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income

Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™ platform of ion implanters at SEMICON Korea 2025. The event is being held February 19th through February 21st, at the COEX Center in Seoul, Korea. SEMICON Korea will highlight key trends shaping the future, including AI, advanced packaging, and sustainable semiconductor manufacturing technologies.

Award Recognizes Companies Who Achieve Highest Level of Safety BEVERLY, Mass., Feb. 3, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, has received the '2024 SK hynix CSO Safety and Health Award'. This prestigious award honors companies whose dedication and commitment in supplying products and services meet SK hynix's high standards for fab site and personal safety. The award was presented by Kim Youngsik, Chief Production Officer (CPO) of SK hynix, at a ceremony held at the SK hynix SUPEX Center in Icheon, Korea. Recipients are a select group of suppliers chosen for their exemplary perfo